ArticleChem & bio engineering2024
Design of Plastic Binding Lytic Polysaccharide Monooxygenases via Modular Engineering.
Article in Chem & bio engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Protein engineering and high-throughput screening of lytic polysaccharide monooxygenases: strategies, challenges, and prospects for industrial applications.World journal of microbiology & biotechnology · 2026Review
- Discovering PETases: An Interlink Between Engineering Enzymes and Microbiomes.Environmental microbiology · 2026Review
- Harnessing Colloidal Dispersion for Laccase-Driven Enzymatic Depolymerization of Polystyrene.Angewandte Chemie (International ed. in English) · 2026Article
- HMethods in molecular biology (Clifton, N.J.) · 2026Article
- A High-Throughput Investigation of the Binding Specificity of Carbohydrate-Binding Modules for Synthetic and Natural Polymers.ChemSusChem · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The worldwide accumulation of plastic waste in the environment, along with its lifespan of hundreds of years, represents a serious threat to ecosystems. Enzymatic recycling of plastic waste offers a promising solution, but the high chemical inertness and hydrophobicity of plastics pose several challenges to enzymes. In nature, lytic polysaccharide monooxygenases (LPMOs) can act at the surface of recalcitrant biopolymers, taking advantage of their solvent-exposed active sites and appended carbohydrate-binding modules (CBMs). LPMOs can disrupt the densely packed chains of polysaccharides (e.g., cellulose) by the oxidation of C-H bonds. Given the similarities between these natural and artificial polymers, we aimed here at promoting plastic-binding properties to LPMOs, by swapping their CBM with three natural, surface-active accessory modules displaying different amphipathic properties. The polymer binding capacity of the resulting LPMO chimeras was assessed on a library of synthetic polymers, including polyester, polyamide, and polyolefin substrates. We demonstrated that the plastic binding properties of these engineered LPMOs are polymer-dependent and can be tuned by playing on the nature of the accessory module and reaction conditions. Remarkably, we gained full binding for some chimera LPMOs with striking results for polyhydroxyalkanoates (PHA). In the long term perspective of harnessing the unique copper chemistry of LPMOs to degrade plastics, we also provided the first evidence of LPMO-dependent modification of the PHA polymer, as supported by enzyme assays, gel permeation chromatography, and scanning electron microscopy. Altogether, our study provides the first roadmap for engineering plastic-binding ability in LPMOs, constituting a crucial first step on the evolutionary path toward efficient interfacial catalysis of plastic-active enzymes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.